无症状阴道念珠菌定植与不良妊娠结局:系统综述与meta分析
该系统综述与meta分析检索至2020年5月,纳入15项研究共33,321名孕妇,评估无症状阴道念珠菌定植与早产等不良妊娠结局的关联。结果显示念珠菌阳性与阴性孕妇的早产率无显著差异(OR 1.10,95%CI 0.99-1.22,I²=0%),且与小于胎龄儿、围产期死亡等结局均无关联。
要点
- 无症状阴道念珠菌定植与早产无显著关联(OR 1.10,95%CI 0.99-1.22)
- 未治疗念珠菌阳性者自发性早产OR 1.28(95%CI 0.90-1.81),无统计学意义
- 念珠菌定植与小于胎龄儿、围产期死亡等不良结局无关
核心结论
- 无症状阴道念珠菌定植与早产及其他不良妊娠结局无显著关联。
- 既往研究提示治疗该微生物可降低早产率,但本结果提示该效应不太可能依赖于治疗阴道念珠菌。
研究设计与样本
- 系统综述与meta分析,检索Ovid MEDLINE、Ovid Embase和Cochrane对照试验中心注册库,从建库至2020年5月6日。
- 纳入队列研究、病例对照研究和随机对照试验,对象为检测无症状阴道念珠菌定植并报告不良妊娠结局的孕妇。
- 由两名评价者独立筛选和提取数据,采用Newcastle-Ottawa量表评价队列和病例对照研究,采用修订版Cochrane偏倚风险工具评价随机对照试验。
主要发现
- 15项研究共33,321名孕妇中,念珠菌阳性与阴性孕妇的早产率无显著差异(OR 1.10,95%CI 0.99-1.22,I²=0%)。
- 仅自发性早产的分析中OR 1.13(95%CI 0.97-1.31,I²=0%),所有早产的分析中OR 1.04(95%CI 0.79-1.35,I²=21%)。
- 亚组分析仅纳入报告自发性早产的研究,未发现治疗策略有统计学显著关联;未治疗念珠菌阳性孕妇OR 1.28(95%CI 0.90-1.81,I²=13%),基于3项研究共5,175名妇女。
- 无症状阴道念珠菌定植与小于胎龄儿、围产期死亡或任何其他不良妊娠结局均无关联。
关键数值与推荐
- 早产率比较:OR 1.10,95%CI 0.99-1.22,I²=0%,基于15项研究33,321名妇女。
- 自发性早产:OR 1.13,95%CI 0.97-1.31,I²=0%。
- 所有早产:OR 1.04,95%CI 0.79-1.35,I²=21%。
- 未治疗念珠菌阳性孕妇自发性早产:OR 1.28,95%CI 0.90-1.81,I²=13%,基于3项研究5,175名妇女。
临床怎么用
- 对于无症状阴道念珠菌定植孕妇,现有证据不支持其与早产等不良结局存在关联。
- 不应仅基于无症状念珠菌定植常规进行抗真菌治疗以预防早产。
- 临床决策应结合其他循证指征,而非针对念珠菌定植本身。
局限性
- 纳入研究以观察性研究为主,可能存在残余混杂。
- 亚组分析中未治疗念珠菌阳性孕妇的样本量有限(3项研究5,175名妇女)。
- 检索截止至2020年5月6日,未纳入此后发表的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: During pregnancy, vaginal colonization by Candida spp is common. Some studies suggest an association between asymptomatic vaginal Candida colonization and adverse pregnancy outcomes, but the evidence is inconsistent. This review aimed to systematically review the association between asymptomatic vaginal colonization by Candida spp and adverse pregnancy outcomes, including preterm birth. DATA SOURCES: We searched Ovid MEDLINE, Ovid Embase, and the Cochrane Central Register of Controlled Trials from inception to May 6, 2020 for published studies on vaginal Candida/yeast and pregnancy outcomes. STUDY ELIGIBILITY CRITERIA: Cohort studies, case-control studies, and randomized controlled trials that included pregnant women who were tested for asymptomatic vaginal Candida colonization and reported on adverse pregnancy outcomes were eligible. STUDY APPRAISAL AND SYNTHESIS METHODS: Two reviewers independently selected and extracted the data. Critical appraisal was performed using the Newcastle-Ottawa Quality Assessment Scale for cohort and case-control studies and the revised Cochrane risk-of-bias tool for randomized controlled trials. RESULTS: We found no significant difference in preterm birth rate between Candida-positive and Candida-negative women (odds ratio, 1.10; 95% confidence interval, 0.99-1.22; I2, 0%) in 15 studies among 33,321 women for either spontaneous preterm birth only (odds ratio, 1.13, 95% confidence interval, 0.97-1.31; I2, 0%) or all preterm birth (odds ratio, 1.04; 95% confidence interval, 0.79-1.35; I2, 21%). Subgroup analyses for a treatment strategy including only studies reporting on spontaneous preterm birth did not reveal any statistically significant associations either, although the odds ratio was increased for the untreated Candida-positive women (odds ratio, 1.28; 95% confidence interval, 0.90-1.81; I2, 13%) in 3 studies among 5175 women. Asymptomatic vaginal Candida colonization was not associated with small for gestational age, perinatal mortality, or any other adverse pregnancy outcome. CONCLUSION: Asymptomatic vaginal Candida colonization is not associated with preterm birth and other adverse pregnancy outcomes. Previous studies reported that treatment of this microorganism reduces preterm birth rate. Our results suggest that this effect is unlikely to rely on treatment of vaginal Candida.
引用
- Schuster HJ, de Jonghe BA, Limpens J, et al. Asymptomatic vaginal Candida colonization and adverse pregnancy outcomes including preterm birth: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020. PMID: 33345884. doi:10.1016/j.ajogmf.2020.100163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。